HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

CRGX

CARGO Therapeutics Inc

Last Close
Oct 15 • 04:00PM ET
21.85
Dollar change
+1.58
Percentage change
7.79 		%
Peers: CRSP VRTX GILD NTLA BMRN PFE BLUE EDIT SGMO QURE
 | Held by: VTI IWM XBI IWN VXF SCHA IWC VTWO VHT ITOT
Scroll to Statements
IndexRUT P/E- EPS (ttm)-3.54 Insider Own31.18% Shs Outstand41.21M Perf Week14.88%
Market Cap1.00B Forward P/E- EPS next Y-4.55 Insider Trans2.01% Shs Float31.59M Perf Month-4.21%
Income-147.71M PEG- EPS next Q-1.11 Inst Own74.46% Short Float16.06% Perf Quarter24.01%
Sales0.00M P/S- EPS this Y74.87% Inst Trans21.29% Short Ratio15.67 Perf Half Y9.25%
Book/sh9.51 P/B2.30 EPS next Y-9.63% ROA- Short Interest5.07M Perf Year-
Cash/sh9.66 P/C2.26 EPS next 5Y- ROE- 52W Range13.14 - 33.92 Perf YTD-5.62%
Dividend Est.- P/FCF- EPS past 5Y- ROI-31.86% 52W High-35.58% Beta-
Dividend TTM- Quick Ratio16.96 Sales past 5Y0.00% Gross Margin- 52W Low66.29% ATR (14)1.33
Dividend Ex-Date- Current Ratio16.96 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)62.74 Volatility7.35% 7.24%
Employees- Debt/Eq0.06 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price31.50
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q-187.82% Payout- Rel Volume1.04 Prev Close20.27
Sales Surprise- EPS Surprise-1.56% Sales Q/Q- EarningsAug 12 AMC Avg Volume323.84K Price21.85
SMA2010.77% SMA5016.78% SMA2008.54% Trades Volume335,195 Change7.79%
Date Action Analyst Rating Change Price Target Change
Jul-22-24Initiated H.C. Wainwright Buy $33
Jul-08-24Initiated Chardan Capital Markets Buy $28
Jun-27-24Initiated Piper Sandler Overweight $37
Dec-05-23Initiated Truist Buy $34
Dec-05-23Initiated TD Cowen Outperform
Dec-05-23Initiated JP Morgan Overweight $23
Dec-05-23Initiated Jefferies Buy $28
Aug-16-24 08:53PM
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024
(InvestorPlace) +5.61%
06:50PM
Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week
(Motley Fool)
Aug-12-24 04:05PM
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
(GlobeNewswire) +5.45%
Jul-10-24 08:00AM
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
(GlobeNewswire)
Jun-04-24 04:05PM
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
(GlobeNewswire)
01:56PM Loading…
01:56PM
Hedge Fund and Insider Trading News: Bill Ackman, Jim Chanos, Daniel Loeb, Mark Yusko, Citadel LLC, CARGO Therapeutics Inc (CRGX), Apple Inc. (AAPL), and More
(Insider Monkey)
May-30-24 06:00AM
Undiscovered Stocks on the Verge of a Breakout: 3 Names to Know Now
(InvestorPlace)
May-28-24 08:05AM
CARGO Therapeutics to Participate in Upcoming Investor Conferences
(GlobeNewswire) -14.33%
08:00AM
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
(GlobeNewswire)
May-22-24 12:00PM
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock
(Zacks)
09:55AM
Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High?
(Zacks)
May-14-24 09:54PM
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q1 2024
(InvestorPlace) +6.55%
04:05PM
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
(GlobeNewswire)
Apr-15-24 04:05PM
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
(GlobeNewswire)
Mar-21-24 10:53PM
CRGX Stock Earnings: Cargo Therapeutics Misses EPS for Q4 2023
(InvestorPlace) -6.23%
04:05PM Loading…
04:05PM
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
(GlobeNewswire)
Feb-29-24 04:01PM
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
(GlobeNewswire)
Jan-03-24 08:05AM
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
(GlobeNewswire) -11.58%
Dec-18-23 04:04PM
Alexandria Snags a Pair of Big Bicoastal Lab Leases
(Commercial Observer) +13.88%
Dec-13-23 10:51PM
CRGX Stock Earnings: Cargo Therapeutics Reported Results for Q3 2023
(InvestorPlace)
04:05PM
CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results
(GlobeNewswire)
Dec-11-23 07:53PM
3 New Stock Listings That Can Deliver Multibagger Returns
(InvestorPlace) -5.55%
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chapman GinaPresident & CEOSep 18 '24Option Exercise5.037,16636,045111,071Sep 20 05:24 PM
Chapman GinaPresident & CEOSep 19 '24Option Exercise5.032,97514,964106,880Sep 20 05:24 PM
Chapman GinaPresident & CEOSep 18 '24Sale25.097,166179,775103,905Sep 20 05:24 PM
Chapman GinaPresident & CEOSep 19 '24Sale25.032,97574,457103,905Sep 20 05:24 PM
Radhakrishnan AnupChief Financial OfficerSep 18 '24Option Exercise5.031,6008,0488,046Sep 20 05:23 PM
Radhakrishnan AnupChief Financial OfficerSep 18 '24Sale25.281,60040,4526,446Sep 20 05:23 PM
ANUP RADHAKRISHNANOfficerSep 18 '24Proposed Sale23.3314,000326,620Sep 18 04:38 PM
GINA CHAPMANDirectorSep 18 '24Proposed Sale23.3375,0001,749,750Sep 18 04:36 PM
Samsara BioCapital GP, LLC10% OwnerMay 30 '24Buy17.00294,0004,998,0004,415,689Jun 03 09:45 PM
Samsara BioCapital GP, LLC10% OwnerNov 14 '23Buy15.00666,6669,999,9904,121,689Nov 16 07:39 PM
Third Rock Ventures V, L.P.10% OwnerNov 14 '23Buy15.001,333,33319,999,9951,807,119Nov 14 07:08 PM
PERCEPTIVE ADVISORS LLCFormer 10% OwnerNov 14 '23Buy15.00666,6669,999,9902,912,835Nov 14 04:32 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.